These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1985780)

  • 1. Tumor-promoting phorbol ester and activated Ha-ras synergistically reduce the interleukin 3 requirement in a mast cell line.
    Imber R; Fabbro D
    Cancer Res; 1991 Jan; 51(2):632-8. PubMed ID: 1985780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. V-Ha-ras-dependent expression of interleukin-3 mRNA in premalignant PB-3c mast cells correlates with the formation of tumors without interleukin-3 gene rearrangements.
    Aebersold DM; Banholzer R; Backenstoss V; Hirsch HH; Moroni C
    Exp Hematol; 1997 May; 25(5):395-404. PubMed ID: 9168061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial down-regulation of protein kinase C in C3H 10T 1/2 mouse fibroblasts transfected with the human Ha-ras oncogene.
    Weyman CM; Taparowsky EJ; Wolfson M; Ashendel CL
    Cancer Res; 1988 Nov; 48(22):6535-41. PubMed ID: 3052806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cells sensitive to v-H-ras transformation are hyperinducible for interleukin 3 expression and have lost tumor-suppressor activity.
    Nair AP; Hirsch HH; Moroni C
    Oncogene; 1992 Oct; 7(10):1963-72. PubMed ID: 1408138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of protein kinase C epsilon is oncogenic in rat colonic epithelial cells.
    Perletti GP; Folini M; Lin HC; Mischak H; Piccinini F; Tashjian AH
    Oncogene; 1996 Feb; 12(4):847-54. PubMed ID: 8632907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A RAS oncogene imparts growth factor independence to myeloid cells that abnormally regulate protein kinase C: a nonautocrine transformation pathway.
    Boswell HS; Nahreini TS; Burgess GS; Srivastava A; Gabig TG; Inhorn L; Srour EF; Harrington MA
    Exp Hematol; 1990 Jun; 18(5):452-60. PubMed ID: 2186924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 1 alpha mediated inhibition of myogenic terminal differentiation: increased sensitivity of Ha-ras transformed cultures.
    Harrington MA; Daub R; Song A; Stasek J; Garcia JG
    Cell Growth Differ; 1992 Apr; 3(4):241-8. PubMed ID: 1325182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased protein kinase C alpha expression in human colonic Caco-2 cells after insertion of human Ha-ras or polyoma virus middle T oncogenes.
    Delage S; Chastre E; Empereur S; Wicek D; Veissiére D; Capeau J; Gespach C; Cherqui G
    Cancer Res; 1993 Jun; 53(12):2762-70. PubMed ID: 8504416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of retinoic acid receptors in mouse skin and skin tumors is associated with activation of the ras(Ha) oncogene and high risk for premalignant progression.
    Darwiche N; Scita G; Jones C; Rutberg S; Greenwald E; Tennenbaum T; Collins SJ; De Luca LM; Yuspa SH
    Cancer Res; 1996 Nov; 56(21):4942-9. PubMed ID: 8895748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C down-regulation, and not transient activation, correlates with melanocyte growth.
    Brooks G; Wilson RE; Dooley TP; Goss MW; Hart IR
    Cancer Res; 1991 Jun; 51(12):3281-8. PubMed ID: 2040003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic action of phorbol ester and IL-3 in the induction of "connective tissue-type" mast cell proliferation.
    Tsuji K; Nakahata T; Takagi M; Kobayashi T; Ishiguro A; Kikuchi T; Naganuma K; Koike K; Miyajima A; Arai K
    J Immunol; 1990 Jan; 144(2):678-84. PubMed ID: 2295806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of tumorigenicity and lack of in vitro growth requirement for 12-O-tetradecanoylphorbol-13-acetate by transfection of murine melanocytes with v-Ha-ras.
    Wilson RE; Dooley TP; Hart IR
    Cancer Res; 1989 Feb; 49(3):711-6. PubMed ID: 2642741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phorbol ester-induced production of cytostatic factors by normal and oncogenic Ha-ras-transformed human breast cell lines.
    Guo M; Reiners JJ
    Carcinogenesis; 2000 Jul; 21(7):1303-12. PubMed ID: 10874007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergy of IL-7 and v-Ha-ras in the in vitro neoplastic progression of murine pre-B cells.
    Chen SC; Redenius D; Young JC; Schwartz RC
    Oncogene; 1993 Aug; 8(8):2119-25. PubMed ID: 8336938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of triiodothyronine and tamoxifen on cell transformation induced by an activated c-Ha-ras oncogene.
    Lopez CA; Hsiao WL; Weinstein IB
    Cancer Res; 1989 Feb; 49(4):895-8. PubMed ID: 2643466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection and preliminary characterization of variant lines of a murine macrophage tumor resistant to the antiproliferative effects of phorbol esters.
    Goode NT; Moore JP; Hart IR
    Cancer Res; 1990 Mar; 50(5):1510-5. PubMed ID: 2105841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction of the ras oncogene transforms a simian virus 40-immortalized hepatocyte cell line without loss of expression of albumin and other liver-specific genes.
    Isom HC; Woodworth CD; Meng Y; Kreider J; Miller T; Mengel L
    Cancer Res; 1992 Feb; 52(4):940-8. PubMed ID: 1371091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of transforming growth factor alpha messenger RNA expression in a chemically transformed rat hepatic epithelial cell line by phorbol ester and hormones.
    Raymond VW; Lee DC; Grisham JW; Earp HS
    Cancer Res; 1989 Jul; 49(13):3608-12. PubMed ID: 2786455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Harvey-ras is biochemically different from Kirsten- or N-ras.
    Carbone A; Gusella GL; Radzioch D; Varesio L
    Oncogene; 1991 May; 6(5):731-7. PubMed ID: 1905005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ras downregulation of protein kinase C mRNA in C3H 10T1/2 fibroblasts.
    Fernandes ER; Ashendel CL
    Mol Carcinog; 1996 Sep; 17(1):23-34. PubMed ID: 8876672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.